Relmada Therapeutics, Inc.
USD6.98
+0.29 (+4.33%)
CEO
Sergio Traversa
IPO Date
2014-06-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$6.61
Prev. Close
$6.69
Day Low
$6.50
Day High
$7.04
52W Low
$0.55
52W High
$8.00
Market Cap
$0.73B
Volume
2.28M
| -0.2 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -115.7% | -101.3% | 0.00 | 8.00 | -0.3 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -111.8% | -102.7% | 0.00 | 12.26 | -0.2 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -60.4% | -56.3% | 0.00 | 14.83 | -0.6 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -56.3% | -50.3% | 0.00 | 9.37 | -1.7 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -13.0% | -12.8% | 0.00 | 80.21 | -4.8 |
| 30 Jun 2019 | FY | 0.0% | 0.0% | -227.5% | -169.5% | 0.05 | 3.83 | -0.5 |
| 30 Jun 2018 | FY | 0.0% | 0.0% | 162.5% | -294.0% | -0.53 | 0.46 | -0.3 |
| 30 Jun 2017 | FY | 0.0% | 0.0% | -430.5% | -221.6% | 0.19 | 1.80 | -0.3 |
| -4.1 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -106.6% | -67.8% | 0.00 | 2.86 | -1.7 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -61.9% | -46.7% | 0.00 | 4.11 | -0.5 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -78.2% | -63.4% | 0.00 | 5.29 | -0.1 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -52.5% | -40.7% | 0.00 | 4.45 | -0.2 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -45.6% | -39.0% | 0.00 | 6.89 | -0.3 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -28.9% | -25.0% | 0.00 | 7.44 | -0.3 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -30.3% | -25.9% | 0.00 | 6.82 | -0.4 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -29.5% | -25.8% | 0.00 | 8.00 | -0.3 |